Marinomed Biotech AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	7.69	4.75	9.06	11.28	11.63
Other Revenue	0.27	0.05	0.34	0.47	-
Revenue	7.96	4.79	9.4	11.74	11.63
Revenue Growth (YoY)	66.08%	-49.01%	-19.96%	1.00%	43.12%
Cost of Revenue	1.42	3.77	8.08	9.4	10.43
Gross Profit	6.54	1.03	1.32	2.35	1.2
Selling, General & Admin	4	4.83	5.05	5.13	4.83
Other Operating Expenses	2.49	2.75	1.83	1.83	1.42
Operating Expenses	6.8	8	7.34	7.63	6.86
Operating Income	-0.26	-6.98	-6.01	-5.28	-5.66
Interest Expense	-0.54	-	-1.38	-2.51	-1.51
Interest & Investment Income	-	-	-	0.04	0.06
Currency Exchange Gain (Loss)	-	0	0	-	-
Other Non Operating Income (Expenses)	0.02	-7.89	0.04	1.11	-0.04
EBT Excluding Unusual Items	-0.79	-14.87	-7.35	-6.64	-7.15
Merger & Restructuring Charges	18.91	-	-	-	-
Gain (Loss) on Sale of Investments	0	-	-	-	-
Gain (Loss) on Sale of Assets	0	0	0	-	-
Asset Writedown	-	-0.65	-	-	-
Other Unusual Items	-	-	0.99	0.24	1.45
Pretax Income	18.12	-15.52	-6.36	-6.39	-5.69
Income Tax Expense	0.11	-0.1	0	0.01	0.2
Net Income	18.02	-15.42	-6.37	-6.4	-5.89
Net Income to Common	18.02	-15.42	-6.37	-6.4	-5.89
Shares Outstanding (Basic)	2	2	2	1	1
Shares Outstanding (Diluted)	2	2	2	1	1
Shares Change (YoY)	3.46%	17.14%	1.29%	1.56%	0.31%
EPS (Basic)	9.79	-8.67	-4.19	-4.27	-3.99
EPS (Diluted)	9.79	-8.67	-4.19	-4.30	-4.00
Free Cash Flow	-1.1	-2.4	-3.7	-5.43	-5.79
Free Cash Flow Per Share	-0.60	-1.35	-2.44	-3.62	-3.92
Gross Margin	82.15%	21.40%	14.07%	20.00%	10.32%
Operating Margin	-3.31%	-145.55%	-63.97%	-44.99%	-48.67%
Profit Margin	226.36%	-321.66%	-67.72%	-54.48%	-50.67%
Free Cash Flow Margin	-13.82%	-50.08%	-39.37%	-46.24%	-49.75%
EBITDA	0.05	-6.56	-5.56	-4.89	-5.28
EBITDA Margin	0.60%	-136.93%	-59.15%	-41.66%	-45.42%
D&A For EBITDA	0.31	0.41	0.45	0.39	0.38
EBIT	-0.26	-6.98	-6.01	-5.28	-5.66
EBIT Margin	-3.31%	-145.55%	-63.97%	-44.99%	-48.67%
Effective Tax Rate	0.58%	-	-	-	-
Revenue as Reported	19.46	0.1	1.49	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.